2021 Update on MRD in acute myeloid leukemia: a consensus document …
2021年12月30日 · Measurable residual disease (MRD) is an important biomarker in acute myeloid leukemia (AML) that is used for prognostic, predictive, monitoring, and efficacy-response …
MRD in AML: who, what, when, where, and how?
2024年1月25日 · In this issue of Blood, Othman et al use retrospective data to show the utility of measurable residual disease (MRD) monitoring of patients with NPM1 acute myeloid leukemia …
Minimal/measurable residual disease in AML: a consensus …
2018年3月22日 · Minimal or, more appropriately, measurable residual disease (MRD) denotes the presence of leukemia cells down to levels of 1:10 4 to 1:10 6 white blood cells (WBCs), …
Using Measurable Residual Disease to Optimize Management of AML…
2023年6月13日 · Measurable residual disease (MRD) is a critical diagnostic tool that predicts disease progression and is increasingly used as an important end point to monitor disease …
Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia ...
Measurable residual disease (MRD) assessment in acute myeloid leukemia (AML) has an established role in disease prognostication, particularly in guiding decisions for hematopoietic …
2021 Update on MRD in acute myeloid leukemia: a consensus
2021年12月30日 · Measurable residual disease (MRD) is an important biomarker in acute myeloid leukemia (AML) that is used for prognostic, predictive, monitoring, and efficacy-response …
Minimal/measurable residual disease in AML: a consensus ... - PubMed
2018年3月22日 · Measurable residual disease (MRD; previously termed minimal residual disease) is an independent, postdiagnosis, prognostic indicator in acute myeloid leukemia (AML) that is …
Measurable Residual Disease in Acute Myeloid Leukemia - FNIH
The MRD in AML project will investigate the use of genetic tests to improve the accuracy of MRD detection approaches, help establish MRD as a validated biomarker in AML, and generate …
MRD in AML: Prognosis, treatment, and surrogate endpoints - AML …
2022年1月21日 · In recent years, the prognostic value of measurable residual disease (MRD) in patients with acute myeloid leukemia (AML) has been established, and early evidence …
MRD in AML: The Role of New Techniques - PMC - PubMed …
In the context of precision medicine, assessment of minimal residual disease (MRD) has been used in acute myeloid leukemia (AML) to direct individual treatment programs, including …
- 某些结果已被删除